Mirum Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC MIRM

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

59,201

Value ($000)

4,676

Weight

0.0%

2022 Q4 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	4,676	0.0%	59,201	12/31/2025
2025 Q3	11/14/2025	4,450	0.0%	60,699	9/30/2025
2025 Q2	8/14/2025	8,218	0.0%	161,490	6/30/2025
2025 Q1	5/19/2025	6,736	0.0%	149,518	3/31/2025
2024 Q4	2/14/2025	3,055	0.0%	73,888	12/31/2024
2024 Q3	11/14/2024	2,475	0.0%	63,461	9/30/2024
2024 Q2	8/14/2024	2,052	0.0%	60,019	6/30/2024
2024 Q1	5/15/2024	1,033	0.0%	41,105	3/31/2024
2023 Q4	2/14/2024	1,205	0.0%	40,805	12/31/2023
2023 Q3	11/13/2023	1,226	0.0%	38,810	9/30/2023
2023 Q2	8/11/2023	549	0.0%	22,849	6/30/2023
2023 Q1	5/15/2023	549	0.0%	22,849	3/31/2023
2022 Q4	2/14/2023	393	0.0%	20,164	12/31/2022